Company news
iX Biopharma Ltd. news in 2020
iX Biopharma Ltd.'s news releases, calls and decks from 2020, newest first.
IX Biopharma is pleased to announce that it has received positive feedback from the European Medicines Agency (EMA) in its scientific advice to the Company regarding its Phase 3 clinical development programme for Wafermine, its sublingual ketamine wafer, for registration in Europe.
November 10, 2020
IX Biopharma obtains approval and registration of Silcap for the treatment of male erectile dysfunction in Singapore
October 21, 2020
IX Biopharma obtains approval and registration of Silcap® for the treatment of male erectile dysfunction in Singapore
October 20, 2020